CRIO Site CTMS vs WeGuide(CTMS)

Research sites, site networks, hospitals and academic medical centers choosing a CTMS to run their own studies, participant visits and site finances. Sponsor and CRO CTMS products are out of scope.

Scope This list serves research sites, not sponsors and CROs. A site CTMS runs participant visits, site budgets and sponsor invoicing; a sponsor or CRO CTMS oversees many sites and countries (monitoring, country start-up, portfolio views). Their workflows differ, so sponsor and CRO products (Veeva Vault CTMS, Oracle Siebel CTMS, Medidata CTMS, IQVIA) belong on a separate list with their own criteria. Products that support participant follow-up alongside a site CTMS are also included; the feature notes distinguish this from dedicated CTMS operations.

Guide updated How we compare

Compare within CTMS

Study fit, side by side

These notes describe the products in the CTMS guide.

CRIO Site CTMS

Best for
Independent sites and site networks that run most studies on eSource and want CTMS in the same system.
What to consider
CRIO's CTMS is built around its eSource, with feasibility searches, screenings and scheduling. Its 2025 security white paper reports 2,500 sites in 30 countries. Its certifications cover its cloud data centers rather than CRIO itself, and it publishes no prices.
Read product profile

WeGuide

Best for
Research sites and study teams that need ongoing participant engagement, screening, consent, questionnaires and follow-up across clinical trials and research studies
What to consider
WeGuide supports the participant-engagement side of running clinical trials and research studies. Screening, consent, questionnaires, reminders and remote follow-up work together in one study program, and dashboards show participant check-ins and questionnaire progress. The Integration Engine connects existing study systems where needed. Sites requiring study budgets, sponsor invoicing or site-wide operational management can use a dedicated CTMS alongside it; the need for additional software depends on those workflows.
Less suitable for
Replacing a site CTMS for study budgets, sponsor invoicing, billing compliance or site-wide operational management.

Study-fit source

Read product profile

Compare the features

Both products use the same category definitions. Product order is editorial; products are not ranked.

Full CTMS feature comparison

Single and double checks describe documented support for an individual feature. Double checks use the extended definition for that feature. Unknown means the available evidence does not establish support.

Expand a feature definition or support note for context and its original source.

CRIO Site CTMS vs WeGuide (CTMS): category feature evidence and sources. Products are not ranked.
Category featureCRIO Site CTMSWeGuide
Study, participant and visit tracking
Feature definitions
Supported
Study participants or visits can be tracked.
Extended support
Participant outreach or pre-screening plus visit scheduling are documented.
Extended support

CRIO's Site CTMS combines a patient database with feasibility searches, phone screenings, pre-screening visits and scheduling that flows straight into eSource.

Source
About this support label

Patient searches and pre-screening combine with scheduling into eSource.

Supported

Dashboards show participant check-ins and questionnaire progress. This is participant follow-up, not a claim of full site visit-calendar or monitoring management.

Source
About this support label

Participant progress is documented; site-wide visit scheduling is not established here.

Site finances
Feature definitions
Supported
Study budgets, invoicing, receivables or payment reconciliation are documented.
Extended support
Study finance workflows include research billing designations or billing-grid links to an EHR.
Supported

It sets visit- and procedure-level receivables, generates and tracks invoices, reconciles sponsor payments, supports GAAP reporting and pays patient stipends, but describes no research billing compliance features.

Source
About this support label

Invoicing and payment reconciliation are stated; research billing compliance is not described.

Unknown

No public evidence reviewed establishes study-budget, sponsor-invoicing or site-receivables workflows in WeGuide. Its published role is a participant layer alongside the CTMS.

Source
About this support label

Unknown does not mean unavailable. The public evidence does not establish support under this category’s definition.

Connected site tools and integrations
Feature definitions
Supported
Integration or data exchange with another system or application is described.
Extended support
Integration with a clinical-trial application plus an API for integration are both stated.
Supported

CRIO combines its own eSource, eConsent, eRegulatory and CTMS and integrates with Veeva Vault EDC and Medidata Rave, but documents no EHR integration or public API.

Source
About this support label

Native trial tools and EDC links establish base support; an EHR link or public API is not documented.

Extended support

The Integration Engine connects participant data with REDCap and other EDC systems using REST or FHIR APIs. Confirm any specific CTMS connector and field mapping.

Source
About this support label

Named clinical-trial system connections and integration APIs meet the shared definition; a specific CTMS connector still needs confirmation.

Proven fit and adoption
Feature definitions
Supported
Published product or wider-platform adoption, or a named clinical-research deployment.
Extended support
Product-specific study, customer, institution, site or participant figures plus a published country count establish international use.
Extended support

CRIO's 2025 security white paper reports 2,500 sites, 6,000 protocols and 5 million patients in 30 countries.

Source
About this support label

Product-specific site, protocol and patient adoption is reported across a stated country count.

Supported

BRACE and INHERIT document participant research deployments. These examples are not CTMS customer counts or evidence that WeGuide performs full site operations.

Source
About this support label

Named research use establishes base support; adoption here concerns the participant platform rather than a CTMS product.

Compliance and security
Feature definitions
Supported
Relevant trial compliance or security controls are stated, with their scope identified.
Extended support
Relevant trial controls and a publicly accessible ISO certificate or SOC audit report covering the product or vendor are documented.
Supported

CRIO says it supports 21 CFR Part 11, HIPAA, EU Annex 11 and GDPR; its SOC 2 and ISO 27001 statements cover its Google Cloud data centers, not CRIO itself.

Source
About this support label

Trial controls are stated; the ISO/SOC claims cover Google Cloud data centers rather than CRIO.

Supported

WeGuide states ISO 27001:2022 certification and support for GDPR, HIPAA and 21 CFR Part 11. The public material does not provide the certificate or an audit report.

Source
About this support label

Public statements establish the documented-support level; no public certificate or audit report establishes extended support.

Published pricing and terms
Feature definitions
Supported
A pricing basis, model or contract terms are published beyond contact sales.
Extended support
Production prices or a free production option are published, with amounts and conditions stated.
Unknown

CRIO publishes no prices or pricing model.

Source
About this support label

The note finds neither published prices nor a pricing model.

Unknown does not mean unavailable. The public evidence does not establish support under this category’s definition.

Supported

WeGuide publishes a per-study quote basis. Contact the team for a study-specific quote; numerical prices are not published.

Source

The guide update date reflects guide edits. Vendor statements are attributed in the evidence.

Keep the category in view

Compare these products with the other tools in the CTMS guide using the same feature definitions.

More CTMS comparisons featuring one of these products.